▲ Peaking
Business
🔮 fades
Ophthalmology venture grabs investors’ attention, raises $330 million
Ollin Biosciences secures $330 million to challenge Roche's Vabsymo in retina disease treatment
Ollin Biosciences
1 trends tracked about this subject — the full history, oldest to newest below.